Mary Riordan, Senior Counsel at the US Health and Human Services Office of Inspector General (HHS-OIG) provided significant updates on current HHS-OIG initiatives, enforcement actions, and upcoming ...
Policy & Medicine offers a daily look at legal, regulatory, and compliance issues affecting the pharmaceutical and device industry. Since its inception in 2008, Policy & Medicine has become one of the ...
The United States Department of Justice (DOJ) recently announced that Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. will pay $450 million to resolve allegations of violating the ...
With Donald Trump now confirmed as the President-elect, the life sciences industry is bracing for significant policy shifts that could impact everything from drug pricing to regulatory practices. Trum ...
ED remedies have been in the works since the 700s, so the issue of getting and maintaining an erection is not a new one. While our ancestors didn’t have the knowledge to create effective erectile ...